Hepatitis Monthly
Official Journal of Research Center for Gastroenterology and Liver Diseases
Scopus by Title (Ref)
1. Development and Validation of a Noninvasive Risk Score Model for Liver Cirrhosis in At-Risk Alcohol Drinkers Without HBV/HCV Infection
- Liu Y. , et al.
3. Ferritin and liver fibrosis among patients with chronic hepatitis C virus infection
- Martín-González C. , et al.
4. Serum cytokines, adipokines and ferritin for non-invasive assessment of liver fibrosis in chronic liver disease: A systematic review
- Haghgoo S. , et al.
5. Severe Vitamin D deficiency increases mortality among patients with liver cirrhosis regardless of the presence of HCC
- Buonomo A.R. , et al.
6. Efficacy of the “first wave” Direct Acting antivirals against HCV infection: Results from the Italian LINA (Liver Network Activity) cohort
- Gentile I. , et al.
8. Investigational direct-acting antivirals in hepatitis C treatment: The latest drugs in clinical development
- Gentile I. , et al.
9. New direct-acting antivirals in hepatitis C therapy: A review of sofosbuvir, ledipasvir, daclatasvir, simeprevir, paritaprevir, ombitasvir and dasabuvir
- McConachie S.M. , et al.
10. An UPLC-MS/MS method for the quantitation of ledipasvir in rat plasma: Application to a pharmacokinetic study
- Zhang K. , et al.
11. The discovery of sofosbuvir: A revolution for therapy of chronic hepatitis C
- Gentile I. , et al.
12. Asunaprevir for hepatitis C: A safety evaluation
- Gentile I. , et al.
13. Current drugs in early development for treating hepatitis C virus-related hepatic fibrosis
- Jaroszewicz J. , et al.
14. Understanding the Complexities of Cirrhosis
- Muir A.J. , et al.
15. Beclabuvir for the treatment of hepatitis C
- Gentile I. , et al.
16. Low vitamin D levels are associated with the presence of serum cryoglobulins in patients with chronic HCV infection
- Gentile I. , et al.
17. GS-9669: A novel non-nucleoside inhibitor of viral polymerase for the treatment of hepatitis C virus infection
- Gentile I. , et al.
18. Cannabinoid receptor 2-63 QQ variant is associated with persistently normal aminotransferase serum levels in chronic hepatitis C
- Coppola N. , et al.
19. Hepatic flares in chronic hepatitis C: Spontaneous exacerbation vs hepatotropic viruses superinfection
- Sagnelli E. , et al.
20. MK-5172: A second-generation protease inhibitor for the treatment of hepatitis C virus infection
- Gentile I. , et al.
21. Efficacy and safety of sofosbuvir in the treatment of chronic hepatitis C: The dawn of a new era
- Gentile I. , et al.
22. Interferon-free therapies for chronic hepatitis C: Toward a hepatitis C virus-free world?
- Gentile I. , et al.
23. Prevention of mother-to-child transmission of hepatitis B virus and hepatitis C virus
- Gentile I. , et al.